3
Views
0
CrossRef citations to date
0
Altmetric
Original

Different behaviour of the N-terminal and C-terminal fragment of proatrial natriuretic factor in plasma of healthy subjects as well as of patients with cirrhosis

, , , , &
Pages 195-198 | Received 01 Jul 1989, Accepted 20 Sep 1989, Published online: 29 Mar 2011

References

  • Cantin M, Genest J. The heart as an endocrine gland. Sci Am 1986; 254: 76–81
  • Needleman P. Atriopeptin: biochemical pharmacology. Federation Proc 1986; 45: 2096–100
  • Thibault G, Murthy K H, Gutkowska J, et al. NH2-terminal fragment of rat proatrial natriuretic factor in the circulation: identification, radioimmunoassay and half-life. Peptides 1988; 9: 47–53
  • Sundsfjord J A, Thibault G, Larochelle P, Cantin M. Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man. J Clin Endocrinol Metabol 1988; 66: 605–10
  • Gerbes A L, Vollmar A M. Water immersion increases the concentration of the immunoreac-tive N-terminal fragment of proatrial natriuretic factor in human plasma. Biochem Biophys Res Comm 1988; 156: 228–32
  • Gauquelin G, Thibault G, Cantin M, Schiffrin E L, Garcia R. Glomerular atrial natriuretic factor receptors during rehydration: plasma NH2- and COOH-terminal levels. Am J Physiol 1988; 255: F621–5
  • Arendt R M, Gerbes A L, Ritter D, Stangl E. Differential processing of plasma atrial natriuretic factor in cardiovascular disease. Biologically Active Atrial Peptides, B M Brenner, J H Laragh. Raven Press, New York 1987; Vol I: 544–7
  • Wernze H, Spech H J, Müller G, Schweinsfurth H, Schöner H, Brügel H. The renin-angiotensin-aldosterone system (RAAS) in chronic liver disease. Aldosterone Antagonists in Clinical Medicine, G M Addison, et al. Excerpta Medica, Amsterdam 1978; 394–404
  • Larose P, Meloche S, du Souich P, De Léan A, Ong H. Radioimmunoassay of atrial natriuretic factor: human plasma levels. Biochem Biophys Res Comm 1985; 130: 553–8
  • Ogihara T, Shima J, Hara H, Kumuhara Y, Kangawa K, Matsuo H. Changes in human plasma atrial natriuretic polypeptide concentration in normal subjects during passive leg raising and whole-body tilting. Clin Sci 1986; 71: 147–50
  • Hodsman G P, Phillips P A, Ogawa K, Johnston C I. Atrial natriuretic factor in normal man: effects of tilt, posture, exercise and hemorrhage. J Hypertension 1986; 4(Suppl. 6)503–5
  • Jüppner H, Brabant G, Kapteina U, Kirschner M, Klein H, Hesch R D. Direct radioimmunoassay for human atrial natriuretic peptide (hANP) and its clinical evaluation. Biochem Biophys Res Comm 1986; 139: 1215–23
  • Gerbes A L, Wernze H, Arendt R M, Riedel A, Sauerbruch T, Paumgartner G. Atrial natriuretic factor and renin-aldosterone in volume regulation of patients with cirrhosis. Hepatology 1989; 9: 417–422
  • Gerbes A L, Arendt R M, Paumgartner G. Editorial review. Atrial natriuretic factor – possible implications in liver disease. J Hepatol 1987; 5: 123–32
  • Gines P, Jiménez W, Arroyo V, et al. Atrial natriuretic factor in cirrhosis with ascites: plasma levels, cardiac release and splanchnic extraction. Hepatology 1988; 8: 636–42
  • Henriksen J H, Schiitten H J, Bendtsen F, Warberg J. Circulating atrial natriuretic peptide (ANP) and central blood volume (CBV) in cirrhosis. Liver 1986; 6: 361–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.